Traditional, complementary and alternative medicine activities
NORGESNAPRAPATENE AS
Revenue 2024
NOK 2.6m
Operating profit
NOK 172,000
Equity
NOK 722,000
Incorporated
2023
Share capital
NOK 30,000
Roles
Daglig lederRoy Kjetil Mittet
Regnskapsfører
Styrets lederRoy Kjetil Mittet
StyremedlemJannike Mittet
StyremedlemYngve Lofthus
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| MITTET INVEST AS | 100.0% | 30000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.